Global Reproductive Genetics Market

Focus on Procedure Type, Product Type, Technology, Application Type, Country Data (15 countries) - Analysis and Forecast, 2020-2030

Published Year: 2021
SKU: BHP1053SA

5250

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Product Definition

1.1    Inclusion and Exclusion

2 Scope of the Research Study

2.1    Key Questions Answered by the Research Study

3 Research Methodology

3.1    Primary Data Sources
3.2    Secondary Data Sources
3.3    Market Estimation Model
3.4    Assumptions and Limitations

4 Market Overview

4.1    Introduction
4.2    Test Performed During Diagnosis
4.3    Market Footprint and Growth Potential
4.4    Future Potential
4.5    Impact of COVID-19 on Global Reproductive Genetics Market
4.6    COVID-19 Affecting Supply Chain of Global Reproductive Genetics Market
4.7    Interruption in Research and Clinical Development and Commercial Operation
         4.7.1    Research and Clinical Development
         4.7.2    Commercial Operation and Access
4.8    Navigating Crisis Recovery and Looking to the Future

5 Global Reproductive Genetics Market: Industry Analysis

5.1    Legal and Regulatory Framework
         5.1.1    Overview
                     5.1.1.1    Regulatory Framework in the U.S.
5.2    Appropriate Use Criteria of Carrier Screening in the U.S.
         5.2.1    Carrier Screening for Familial Disease
                      5.2.1.1    Fragile X Syndrome
         5.2.2    Carrier Screening for Common and Ethnic Genetic Diseases
                     5.2.2.1    Cystic Fibrosis
                     5.2.2.2    Spinal Muscular Atrophy
                     5.2.2.3    Hemoglobinopathies
                     5.2.2.4    Ashkenazi Jewish Carrier Screening
        5.2.3    Other Ethnicities
        5.2.4    Regulatory Framework in the European Union
        5.2.5    Germany
        5.2.6    France
        5.2.7    U.K.
        5.2.8    Spain
5.3    Regulations in Asia-Pacific (APAC)
         5.3.1    China
         5.3.2    Japan
         5.3.3    South Korea

6 Patent Landscape

Patent Landscape

7 Global Reproductive Genetics Market Dynamics

7.1    Impact Analysis
7.2    Market Drivers
         7.2.1    The Declining Cost of Genetic Sequencing Technologies
         7.2.2    Increasing Awareness and Acceptance for Genetic Testing and Screening
         7.2.3    Rising Emphasis on Early Detection and Prevention
         7.2.4    Rising Maternal Age Leading to Pregnancy Complications
7.3    Market Restraints
         7.3.1    Lack of regulations
         7.3.2    Ethical and Social Issues
7.4    Market Opportunities
         7.4.1    Shifting of Reimbursement Policies toward Enhanced Genetics Coverage
         7.4.2    Rising Funding and Innovations
         7.4.3    Increasing Consumer Demand

8 Global Reproductive Genetics Market: Competitive Landscape

8.1    Overview
8.2    Key Developments and Strategies
8.3    New Offerings
8.4    Synergistic Activities
8.5    Product Approval
8.6    Business Expansion
8.7    Market Share Analysis
8.8    Growth-Share Analysis

9 Global Reproductive Genetics Market (by Procedure Type), $Million, 2020-2030

9.1    Overview
9.2    Carrier Screening
9.3    Pre-Natal Screening
9.4    Pre-Implantation Genetic Testing
9.5    Infertility Genetic Testing

10 Global Reproductive Genetics Market (by Product Type), 2020-2030, ($Million)

10.1    Overview
10.2    Kits
10.3    Laboratory Developed Tests (LDT)
10.4    Reagents and Consumables

11 Global Reproductive Genetics Market (by Technology), 2020-2030, ($Million)

11.1    Next-Generation Sequencing
11.2    Polymerase Chain Reaction
11.3    In Situ Hybridization (ISH/FISH)
11.4    Microarray

12 Global Reproductive Genetics Market (by Application Type), 2020-2030, ($Million)

12.1    Overview
12.2    Aneuploidy
12.3    Structural Chromosomal Abnormality
12.4    Single Gene Disorder
12.5    Others

13 Global Reproductive Genetics Market (by Region), 2020-2030, ($Million)

13.1    Overview
13.2    North America
           13.2.1    North America: Market Dynamics
           13.2.2    U.S.
           13.2.3    Canada
13.3    Europe
           13.3.1    Europe: Market Dynamics
           13.3.2    U.K.
           13.3.3    Germany
           13.3.4    France
           13.3.5    Italy
           13.3.6    Spain
           13.3.7    Rest-of-Europe
13.4    Asia-Pacific
           13.4.1    Asia-Pacific: Market Dynamics
           13.4.2    Japan
           13.4.3    China
           13.4.4    India
           13.4.5    Australia
           13.4.6    South Korea
           13.4.7    Rest-of-Asia-Pacific
13.5    Latin America
           13.5.1    Latin America: Market Dynamics
           13.5.2    Brazil
           13.5.3    Mexico
           13.5.4    Rest-of-Latin-America
13.6    Rest-of-the-World

14 Company Profiles

14.1    Overview
14.2    Agilent Technologies, Inc.
           14.2.1    Company Overview
           14.2.2    Role of Agilent Technologies, Inc. in the Global Reproductive Genetics Market
           14.2.3    Financials
           14.2.4    SWOT Analysis
14.3    BGI
           14.3.1    Company Overview
           14.3.2    Role of BGI Group in Global Reproductive Genetics Market
           14.3.3    SWOT Analysis
14.4    CENTOGENE AG
           14.4.1    Company Overview
           14.4.2    Role of Centogene AG in the Global Reproductive Genetics Market
           14.4.3    SWOT Analysis
14.5    Fulgent Genetics, Inc.
           14.5.1    Company Overview
           14.5.2    Role of Fulgent Genetics, Inc. in the Global Reproductive Genetics Market
           14.5.3    Financials
           14.5.4    SWOT Analysis
14.6    F. Hoffmann-La Roche Ltd
           14.6.1    Company Overview
           14.6.2    Role of F. Hoffman-LA Roche Ltd in the Global Reproductive Genetics Market
           14.6.3    Financials
           14.6.4    SWOT Analysis
14.7    Igenomix
           14.7.1    Company Overview
           14.7.2    Role of Igenomix in the Global Reproductive Genetics Market
           14.7.3    SWOT Analysis
14.8    Illumina, Inc.
           14.8.1    Company Overview
           14.8.2    Role of Illumina, Inc. in the Global Reproductive Genetics Market
           14.8.3    Financials
           14.8.4    SWOT Analysis
14.9    Invitae Corporation
           14.9.1    Company Overview
           14.9.2    Role of Invitae Corporation in the Global Reproductive Genetics Market
           14.9.3    Financials
           14.9.4    SWOT Analysis
14.10    Laboratory Corporation of America Holdings
             14.10.1    Company Overview
             14.10.2    Role of Laboratory Corporation of America Holdings in the Global Reproductive Genetics Market
             14.10.3    Financials
             14.10.4    SWOT Analysis
14.11    PerkinElmer, Inc.
             14.11.1    Company Overview
             14.11.2    Role of PerkinElmer, Inc. in the Global Reproductive Genetics Market
             14.11.3    Financials
             14.11.4    SWOT Analysis
14.12    Myriad Genetics, Inc.
             14.12.1    Company Overview
             14.12.2    Role of Myriad Genetics, Inc. in the Global Reproductive Genetics Market
             14.12.3    Financials
             14.12.4    Key Insights About Financial Health of the Company
             14.12.5    SWOT Analysis
14.13    OPKO Health, Inc.
             14.13.1    Company Overview
             14.13.2    Role of OPKO Health, Inc. in the Global Reproductive Genetics Market
             14.13.3    Financials
             14.13.4    SWOT Analysis
14.14    Quest Diagnostics
             14.14.1    Company Overview
             14.14.2    Role of Quest Diagnostics in the Global Reproductive Genetics Market
             14.14.3    Financials
             14.14.4    SWOT Analysis
14.15    QIAGEN N.V.
             14.15.1    Company Overview
             14.15.2    Role of QIAGEN N.V. in the Global Reproductive Genetics Market
             14.15.3    Financials
             14.15.4    SWOT Analysis
14.16    Thermo Fisher Scientific Inc.
             14.16.1    Company Overview
             14.16.2    Role of Thermo Fisher Scientific Inc. in the Global Reproductive Genetics Market
             14.16.3    Financials
             14.16.4    SWOT Analysis

List of Tables

Table 5.1:    Regulatory Bodies Governing Genetic Testing
Table 7.1:    Declining Cost of Genome
Table 12.1:    Incidence of Aneuploidies
Table 12.2:    Global Incidence of Major Single Gene Disorders

List of Figures

Figure 1    : Global Prevalence of Congenital Abnormalities (2015-2019)
Figure 2:    Global Reproductive Genetics Market, 2020-2030
Figure 3:    Market Drivers, Market Opportunities and Market Restraints
Figure 4:    Share of Key Developments and Strategies, Global Reproductive Genetics Market, January 2017-February 2021
Figure 5:    Growth-Share Analysis: Global Reproductive Genetics Market (by Company), 2020
Figure 2.1:    Global Reproductive Genetics Market Segmentation
Figure 3.1:    Global Reproductive Genetics Market Research Methodology
Figure 3.2:    Primary Research Methodology
Figure 3.3:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 4.1:    Type of Reproductive Genetic Tests
Figure 4.2:    Positive and Negative Impact of COVID-19 on Global Reproductive Genetics Market
Figure 4.3:    Pre-COVID-19 and Post-COVID-19 Scenario, Global Reproductive Genetics Market, 2020-2025
Figure 4.4:    Measure to Navigate Crisis Recovery
Figure 6.1:    Number of Patents (by Year), 2016-2020
Figure 7.1:    Impact Analysis
Table 7.1:    Declining Cost of Genome
Figure 8.1:    Share of Key Developments and Strategies, January 2017-March 2021
Figure 8.2:    Product Offering Share (by Company), January 2017-January 2021
Figure 8.3:    Synergistic Activities Share (by Company), January 2017-January 2021
Figure 8.4:    Product Approval Share (by Company), January 2017-January 2021
Figure 8.5:    Business Expansion Activities (by Company), January 2017-January 2021
Figure 8.6:    Market Share Analysis: Global Reproductive Genetics Market Share Analysis (by Company), 2020
Figure 8.7:    Growth-Share Analysis: Global Reproductive Genetics Market (by Company), 2020
Figure 9.1:    Share of Global Reproductive Genetics Market (by Procedure Type), $Million, 2020-2030
Figure 9.2:    Global Reproductive Genetics Market (Carrier Screening), $Million,  2020-2030
Figure 9.3:    Global Reproductive Genetics Market (Pre-Natal Screening), $Million,2020-2030
Figure 9.4:    Global Reproductive Genetics Market (Pre-Implantation Genetic Testing), $Million,2020-2030
Figure 9.5:    Global Reproductive Genetics Market (Infertility Genetic Testing), $Million, 2020-2030
Figure 10.1:    Share of Global Reproductive Genetics Market (by Product Type), $Million, 2020-2030
Figure 10.2:    Global Reproductive Genetics Market (Kits), $Million, 2020-2030
Figure 10.3:    Reproductive Genetics Market (LDT), $Million, 2020-2030
Figure 10.4:    Global Reproductive Genetics Market (Reagents and Consumables), $Million, 2020-2030
Figure 11.1:    Share of Global Reproductive Genetics Market (by Technology), $Million, 2020-2030
Figure 11.2:    Global Reproductive Genetics Market (Next-Generation Sequencing), $Million, 2020-2030
Figure 11.3:    Global Reproductive Genetics Market (PCR), $Million, 2020-2030
Figure 11.4:    Global Reproductive Genetics Market (ISH), $Million, 2020-2030
Figure 11.5:    Global Reproductive Genetics Market (Microarray), $Million, 2020-2030
Figure 12.1:    Global Reproductive Genetics Market, $Million, 2020 and 2030
Figure 12.2:    Global Reproductive Genetics Market (Aneuploidy), $Million, 2020-2030
Figure 12.3:    Types of Structural Chromosomal Abnormality
Figure 12.4:    Global Reproductive Genetics Market (Structural Chromosomal Abnormality), $Million, 2020-2030
Figure 12.5:    Pedigree Analysis of Inheritance Pattern of a Dominant Disease
Figure 12.6:    Pedigree Analysis of Inheritance Pattern of a Recessive Disease
Figure 12.7:    Global Reproductive Genetics Market (Single Gene Disorders), $Million, 2020-2030
Figure 12.8:    Global Reproductive Genetics Market (by Others), $Million, 2020-2030
Figure 13.1:    Global Reproductive Genetics Market (by Region)
Figure 13.2:    North America Reproductive Genetics Market, $Million ,(2020-2030)
Figure 13.3:    North America: Market Dynamics
Figure 13.4:    North America Reproductive Genetics Market (by Country), $Million, 2020-2030
Figure 13.5:    U.S. Reproductive Genetics Market, $Million, 2020-2030
Figure 13.6:    Canada Reproductive Genetics Market, $Million, 2020-2030
Figure 13.7:    Europe Reproductive Genetics Market, $Million, 2020-2030
Figure 13.8:    Europe: Market Dynamics
Figure 13.9:    Europe: Reproductive Genetics Market (by Country), 2020 and 2030
Figure 13.10:    U.K. Reproductive Genetics Market, $Million, 2020-2030
Figure 13.11:    Germany Reproductive Genetics Market, $Million, 2020-2030
Figure 13.12:    Number of Live Births in Germany (2012-2018)
Figure 13.13:    France Reproductive Genetics Market, $Million, 2020-2030
Figure 13.14:    Italy Reproductive Genetics Market, $Million, 2020-2030
Figure 13.15:    Spain Reproductive Genetics Market, $Million, 2020-2030
Figure 13.16:    Rest-of-Europe Reproductive Genetics Market, $Million, 2020-2030
Figure 13.17:    Asia-Pacific Reproductive Genetics Market, $Million, 2020-2030
Figure 13.18:    Asia-Pacific: Market Dynamics
Figure 13.19:    Asia-Pacific Reproductive Genetics Market (by Country), 2020 and 2030
Figure 13.20:    Japan Reproductive Genetics Market, $Million, 2020-2030
Figure 13.21:    China Reproductive Genetics Market, $Million, 2020-2030
Figure 13.22:    India Reproductive Genetics Market, $Million, 2020-2030
Figure 13.23:    Australia Reproductive Genetics Market, $Million, 2020-2030
Figure 13.24:    South Korea Reproductive Genetics Market, $Million, 2020-2030
Figure 13.25:    Rest-of-Asia-Pacific Reproductive Genetics Market, $Million, 2020-2030
Figure 13.26:    Latin America Reproductive Genetics Market, $Million, 2020-2030
Figure 13.27:    Latin America: Market Dynamics
Figure 13.28:    Latin America Reproductive Genetics Market (by Country),  2020 and 2030
Figure 13.29:    Brazil Reproductive Genetics Market, $Million, 2020-2030
Figure 13.30:    Mexico Reproductive Genetics Market, $Million, 2020-2030
Figure 13.31:    Rest-of-Latin-America Reproductive Genetics Market, $Million,  2020-2030
Figure 13.32:    Rest-of-the-World Reproductive Genetics Market, $Million, 2020-2030
Figure 14.1:    Shares of Key Company Profiles
Figure 14.2:    Agilent Technologies, Inc.: Overall Product Offerings
Figure 14.3:    Agilent Technologies, Inc.: Overall Financials, 2018-2020
Figure 14.4:    Agilent Technologies, Inc.: Net Revenue (by Business Segment),  2018-2020
Figure 14.5:    Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 14.6:    Agilent Technologies, Inc.: Research and Development Expense,  2018-2020
Figure 14.7:    Agilent Technologies, Inc.: SWOT Analysis
Figure 14.8:    BGI Group.: Overall Product Portfolio
Figure 14.9:    BGI Group: SWOT Analysis
Figure 14.10:    CENTOGENE AG: Overall Product Offerings
Figure 14.11:    Centogene AG: SWOT Analysis
Figure 14.12:    Fulgent Genetics, Inc..: Overall Product Offerings
Figure 14.13:    Fulgent Genetics, Inc.: Overall Financials, 2018-2020
Figure 14.14:    Fulgent Genetics, Inc.: Net Revenue (by Region), 2018-2020
Figure 14.15:    Fulgent Genetics, Inc.: Research and Development Expense, 2018-2020
Figure 14.16:    Fulgent Genetics, Inc.: SWOT Analysis
Figure 14.17:    F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 14.18:    F. Hoffmann-La Roche Ltd: Overall Financials, 2018-2020
Figure 14.19:    F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2018-2020
Figure 14.20:    Hoffmann-La Roche Ltd: Revenue (by Region), 2018-2020
Figure 14.21:    F. Hoffmann-La Roche Ltd: R&D Expenditure, 2018-2020
Figure 14.22:    F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 14.23:    Igenomix :  Overall Product Portfolio
Figure 14.24:    Igenomix.: SWOT Analysis
Figure 14.25:    Illumina, Inc.: Overall Product Portfolio
Figure 14.26:    Illumina, Inc.: Overall Financials, 2018-2020
Figure 14.27:    Illumina, Inc.: Revenue (by Segment), 2018-2020
Figure 14.28:    Illumina, Inc.: Revenue (by Region), 2018-2020
Figure 14.29:    Illumina, Inc.: R&D Expenditure, 2018-2020
Figure 14.30:    Illumina, Inc.: SWOT Analysis
Figure 14.31:    Invitae Corporation:  Overall Product Offerings
Figure 14.32:    Invitae Corporation: Overall Financials, 2018-2020
Figure 14.33:    Invitae Corporation: Revenue (by Segment), 2018-2020
Figure 14.34:    Invitae Corporation: Revenue (by Region), 2018-2020
Figure 14.35:    Invitae Corporation: R&D Expenditure, 2018-2020
Figure 14.36:    Invitae Corporation: SWOT Analysis
Figure 14.37:    Laboratory Corporation of America Holdings: Overall Product Portfolio
Figure 14.38:    Laboratory Corporation of America Holdings: Overall Financials,  2018-2020
Figure 14.39:    Laboratory Corporation of America Holdings: Revenue (by Segment),  2018-2020
Figure 14.40:    Laboratory Corporation of America Holdings: Revenue (by Region), 2019
Figure 14.41:    Laboratory Corporation of America Holdings: SWOT Analysis
Figure 14.42:    PerkinElmer, Inc.: Overall Product Offerings
Figure 14.43:    PerkinElmer, Inc: Overall Financials, 2018-2020
Figure 14.44:    PerkinElmer, Inc.: Revenue (by Segment), 2018-2020
Figure 14.45:    PerkinElmer, Inc.: R&D Expenditure, 2018-2020
Figure 14.46:    PerkinElmer, Inc.: SWOT Analysis
Figure 14.47:    Myriad Genetics, Inc.: Product Portfolio
Figure 14.48:    Myriad Genetics, Inc.: Overall Financials, 2018-2020
Figure 14.49:    Myriad Genetics, Inc.: Revenue (by Business Segment), 2018-2020
Figure 14.50:    Myriad Genetics, Inc.: R&D Expenditure, 2018-2020
Figure 14.51:    Myriad Genetics, Inc.: SWOT Analysis
Figure 14.52:    OPKO Health, Inc.: Overall Product Offerings
Figure 14.53:    OPKO Health, Inc.: Overall Financials, 2017-2019
Figure 14.54:    OPKO Health, Inc: Net Revenue (by Business Segment), 2017-2019
Figure 14.55:    OPKO Health, Inc.: Net Revenue (by Region), 2017-2019
Figure 14.56:    OPKO Health, Inc.: Research and Development Expenditure, 2017-2019
Figure 14.57:    OPKO Health, Inc.: SWOT Analysis
Figure 14.58:    Quest Diagnostics Incorporated: Overall Product Offerings
Figure 14.59:    Quest Diagnostics Incorporated: Overall Financials, 2018-2020
Figure 14.60:    Quest Diagnostics Incorporated: Revenue (by Business Segment),  2018-2020
Figure 14.61:    Quest Diagnostics Incorporated: SWOT Analysis
Figure 14.62:    QIAGEN N.V.: Overall Product Portfolio
Figure 14.63:    QIAGEN N.V.: Overall Financials, 2017-2019
Figure 14.64:    QIAGEN N.V.: Revenue (by Segment), 2017-2019
Figure 14.65:    QIAGEN N.V.: Revenue (by Region), 2017-2019
Figure 14.66:    QIAGEN N.V.: R&D Expenditure, 2017-2019
Figure 14.67:    QIAGEN N.V.: SWOT Analysis
Figure 14.68:    Thermo Fisher Scientific Inc.: Overall Product Portfolio
Figure 14.69:    Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
Figure 14.70:    Thermo Fisher Scientific Inc.: Revenue (by Segment), 2018-2020*
Figure 14.72:    Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
Figure 14.73:    Thermo Fisher Scientific Inc.: SWOT Analysis

FAQ's

What is the current market size of global reproductive genetics market?

In 2020, the global reproductive genetics market generated $4.40 billion and is projected to reach the mark of $12.93 billion by 2030.

What are the growth drivers for the reproductive genetics industry?

Factors such as the declining cost of genetic sequencing technologies, increasing awareness and acceptance for genetic testing and screening, rising emphasis on early detection and prevention, and rising maternal age leading to pregnancy complications, favour the growth of this emerging tech. 

Are there any challenges associated with the rise of reproductive genetics market?

Lack of regulations and, ethical and social issues, are some challenges that hinder the adoption of reproductive genetics by healthcare institutions/companies.

Which region holds the largest market share in the reproductive genetics market?

Based on region, North America dominates the global reproductive genetics industry due to improved healthcare infrastructure, rise in awareness, and improvised reimbursement policies in the region. 

Who are the key players operating in the market?

Major players involved in the reproductive genetics market are Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc., BGI, CooperSurgical, Inc., Centogene AG.

You may also like

Published Year: 2020

Global NIPT Market: Focus on Test Type, Platform, Method, Application, End-User, 5 Regional Data, 25

By volume, global NIPT market was 3.14 million units in 2019 and is expected to reach 23.58...

 
Published Year: 2019

Global Carrier Screening Market – Analysis and Forecast, 2019-2029: Focus on Product Type, Technol

The global carrier screening market was valued at $846.9 million in 2018 and is estimated to...

 

Global Reproductive Genetics Market

Focus on Procedure Type, Product Type, Technology, Application Type, Country Data (15 countries) - Analysis and Forecast, 2020-2030